4.02 USD
-0.21 (-4.96%)
Last: Feb 4, 2026, 04:30 PM
ChartMill assigns a Buy % Consensus number of 83% to QTTB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 11.56. This target is 187.56% above the current price.
- QTTB was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QTTB.
- In the previous month the buy percentage consensus was at a similar level.
- QTTB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-11 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-02-11 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-12-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-12-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-12-11 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-11 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-11 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2024-12-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-10-24 | Raymond James | Initiate | Strong Buy |
| 2024-09-11 | Wells Fargo | Initiate | Overweight |
| 2024-06-17 | Guggenheim | Initiate | Buy |
| 2024-05-21 | Leerink Partners | Initiate | Outperform |
| 2024-04-11 | Oppenheimer | Initiate | Outperform |
| 2024-04-02 | Piper Sandler | Initiate | Overweight |
Q32 BIO INC / QTTB FAQ
What do analysts expect the price target to be for Q32 BIO INC (QTTB)?
8 analysts have analysed QTTB and the average price target is 11.56 USD. This implies a price increase of 187.56% is expected in the next year compared to the current price of 4.02.
What is the consensus rating for QTTB stock?
The consensus rating for Q32 BIO INC (QTTB) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.